Abstract:Tumor is one of the most serious threats for human being. Although many anti-tumor drugs are approved for clinical use, the treatment outcome is still modest because of the poor tumor targeting efficiency and low accumulation in tumor. Therefore, it is important to deliver anti-tumor drug into tumor efficiently, elevate drug concentration in tumor tissues and reduce the drug distribution in normal tissues. And it has been one of the most attractive directions of pharmaceutical academy and industry. Many kinds of strategies, especially various nanoparticulated drug delivery systems, have been developed to address the critical points of complex tumor microenvironment, which are partially or mostly satisfied for tumor treatment. In this paper, we carefully reviewed the novel targeting delivery strategies developed in recent years. The most powerful method is passive targeting delivery based on the enhanced permeability and retention(EPR) effect, and most commercial nanomedicines are based on the EPR effect. However, the high permeability and retention require different particle sizes, thus several kinds of size-changeable nanoparticles are developed, such as size reducible particles and assemble particles, to satisfy the controversial requirement for particle size and enhance both tumor retention and penetration. Surface charge reversible nanoparticles also shows a high efficiency because the anionic charge in blood circulation and normal organs decrease the unintended internalization. The charge can change into positive in tumor microenvironment, facilitating drug uptake by tumor cells. Additionally, tumor microenvironment responsive drug release is important to decrease drug side effect, and many strategies are developed, such as p H sensitive release and enzyme sensitive release. Except the responsive nanoparticles, shaping tumor microenvironment could attenuate the barriers in drug delivery, for example, decreasing tumor collagen intensity and normalizing tumor microvessels to decrease the internal fluid pressure. All these strategies could enhance the accumulation and penetration of nanoparticles into tumor, leading to a homogenous distribution of drugs in tumor. To enhance the internalization by specific cells, active targeting delivery strategies are developed. There were many surface markers, receptors or carriers overexpressed on specific kinds of cells, thus the corresponding ligands were utilized to mediate active targeting to certain cells, including tumor cells, cancer stem cells, tumor neovasculatures, tumor associated macrophages and other tumor stroma cells. Targeting more than one cell type may provide an improved antitumor effect. Although these passive and active targeting strategies all have promising outcome in the treatment of tumor, some shortages are still unaddressed, such as the specificity of responsive is not good enough, and the active targeting may be diminished by the protein corona. Thus more research is required to promote the drug delivery study.

Application of Nanoparticles with Targeting,Triggered Release in Anti-Cancer Drug Delivery

“Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems

Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release

Nanomaterials in Cancer-Therapy Drug Delivery System

Effect of Surface Chemistry Modification of Functional Gold Nanoparticles on the Drug Accumulation of Cancer Cells

Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery

Nanoparticles for tumor targeted therapies and their pharmacokinetics.

Chemo-drug Controlled-release Strategies of Nanocarrier in the Development of Cancer Therapeutics

The Design and Application of Nanomaterials as Drug Carriers in Cancer Treatment

The Smart Dual-Stimuli Responsive Nanoparticles for Controlled Anti-Tumor Drug Release and Cancer Therapy

Cell Membrane-Coated Nanoparticles for Tumor-Targeted Drug Delivery

Targeting nanoparticles to cancer

Cancer nanomedicine: from targeted delivery to combination therapy

Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment

[The Development of Novel Tumor Targeting Delivery Strategy].

Ultrasound-Based Drug Delivery System

Applications of Gold Nanoparticles in Cancer Nanotechnology.

Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy

Breast tumor‐targeted drug delivery via polymer nanocarriers: Endogenous and exogenous strategies

Enhanced nanoparticle delivery exploiting tumour-responsive formulations

Recent Advances in Nanotechnology-Based Targeted Delivery Systems of Active Constituents in Natural Medicines for Cancer Treatment